| 1999 |
Ribosomal protein L10e (uL10/RPLP0) is required for sordarin sensitivity in yeast; mutations in a conserved 10-amino acid region of L10e confer resistance to the eEF2 inhibitor sordarin by reducing sordarin-stabilized eEF2-nucleotide-ribosome complex formation, establishing a functional linkage between L10e and translocation by eEF2. |
Biochemical and molecular genetic analysis of sordarin-resistant mutants; sequencing of L10e alleles; in vitro eEF2-ribosome-nucleotide complex stabilization assays |
The Journal of biological chemistry |
High |
9988728
|
| 1995 |
Ricin A chain physically cross-links to ribosomal proteins L9 and L10e (RPLP0) on mammalian ribosomes, identifying L10e as a ribosome-surface component accessible to the toxin; ricin A chain localizes to the endoplasmic reticulum and nucleoli in permeabilized cells. |
Chemical cross-linking with 125I-labeled ricin A chain on purified mammalian ribosomes; tryptic peptide sequencing; indirect immunofluorescence; competition with excess unlabeled ricin A chain as specificity control |
The Journal of biological chemistry |
High |
7759553
|
| 1991 |
In the archaebacterium Sulfolobus solfataricus, L10e (uL10) is a near neighbor of L12e (the L7/L12 homolog) in the large ribosomal subunit, forming part of a pentameric (L12e)4–L10e complex that constitutes the factor-binding domain; this organization is conserved across eubacteria, archaea, and eukaryotes. |
Chemical cross-linking with 2-iminothiolane; two-dimensional diagonal SDS-PAGE; N-terminal sequencing of cross-linked partners |
The Journal of biological chemistry |
Medium |
1939187
|
| 2002 |
Overexpression of yeast ribosomal protein Rpp0 (uL10/RPLP0 ortholog) cures prion determinants [PSI+PS] and [PSI+] in a prion-strain-specific manner, at least partly by modulating chaperone-related promoter activity (SSA4, HSP104). |
Multicopy yeast genomic library screen; prion curing assays; promoter-reporter assays for chaperone gene expression |
The Journal of biological chemistry |
Medium |
11923285
|
| 2017 |
Upon nucleolar stress, the uL10 (RPLP0) protein is released from pre-existing ribosomes and accumulates in the cytoplasm as a ribosome-free pool in mammalian cells, indicating a stress-responsive regulatory role beyond translation. |
Biochemical fractionation; advanced fluorescence microscopy; FRAP after photoconversion (FRAP-AC) in mammalian cells |
Biochimica et biophysica acta. Molecular cell research |
High |
28986221
|
| 2020 |
Phosphorylation within the N-terminal rRNA-binding domain of uL10 (RPLP0) impairs its association with the ribosome; introduction of a negative charge at N-terminal sites reduces ribosome binding, revealing a phosphorylation-dependent regulatory mechanism governing P-stalk assembly and GTPase-associated center activity. |
Phosphorylation site mapping; mutagenesis introducing negative charge mimics; ribosome association assays |
FEBS letters |
Medium |
32668052
|
| 2019 |
The extended protuberant (uL10ext) domain of eukaryotic uL10 (RPLP0) contains a conserved 'hinge' region around Phe183 that undergoes conformational rearrangement; substitution of the equivalent yeast residue (F181A) increases polyphenylalanine synthesis ~33% in an in vitro translation assay, demonstrating that hinge motion facilitates binding of translation factors to the GTPase-associated center. |
NMR structure determination (solution structure of uL10ext domain from Bombyx mori); 15N relaxation analysis; yeast mutant strain construction; in vitro translation assay |
Biochemistry |
High |
31419120
|
| 2014 |
RPLP0 interacts with cathepsin X/Z (CTSX) in gastric cancer cells; knockdown of RPLP0 causes G1 cell cycle arrest and down-regulates CDK2, and affects p21 expression (but not Cyclin E), placing RPLP0 as an anti-apoptotic regulator; CTSX knockdown causes nuclear translocation of RPLP0. |
Yeast two-hybrid; co-immunoprecipitation; co-localization by laser-scan microscopy; siRNA knockdown; cell cycle analysis; western blotting |
Pathology, research and practice |
Medium |
25433997
|
| 2019 |
RPLP0 physically interacts with the tumor suppressor PLAAT4; RPLP0 protein levels are suppressed in PLAAT4-expressing cells, and RPLP0 silencing phenocopies PLAAT4 expression (decreased viability, reduced cell-cycle and anti-apoptotic proteins), indicating RPLP0 mediates PLAAT4-induced cell cycle arrest and apoptosis. |
Yeast two-hybrid screening; co-immunoprecipitation; co-localization; siRNA knockdown; cell viability assays; western blotting |
Cell biochemistry and biophysics |
Medium |
31131438
|
| 2010 |
RPLP0 functions as a cell-surface receptor on mammary endothelial cells during lactation, mediating binding and internalization of the MG1 homing peptide (CLHQHNQMC) identified by in vivo phage display. |
In vivo phage display biopanning; peptide affinity pull-down assay; immunoblotting; in vitro endothelial cell internalization assay; competitive inhibition with synthetic peptide |
Peptides |
Medium |
20863866
|
| 2022 |
An alternatively spliced isoform of uL10 (named uL10β) is stably expressed in mammalian cells, localizes predominantly to the nucleus, can associate with 60S and 80S ribosomal particles, and undergoes re-localization to mitochondria upon ER stress, suggesting a specialized stress-related function. |
RT-PCR/sequencing of isoform; subcellular fractionation; fluorescence microscopy; ribosome sedimentation assays; ER stress induction experiments |
Biochimica et biophysica acta. Gene regulatory mechanisms |
Medium |
36328276
|
| 2008 |
Overexpression of yeast RPP0 (RPLP0 ortholog) enhances secretion of heterologous proteins; the effect does not appear to involve ribosome function directly, but instead RPP0 overexpression prevents upregulation of the yeast plasma membrane H+-ATPase gene PMA1, thereby limiting medium acidification. |
Gene overexpression in S. cerevisiae; secretion yield assays; gene expression analysis of PMA1 |
Biotechnology progress |
Low |
18396911
|
| 2024 |
RPLP0 knockdown activates apoptosis signaling in human umbilical vein endothelial cells and enhances endothelial permeability; TNF-α treatment combined with RPLP0 knockdown synergistically increases these effects, placing RPLP0 as an anti-apoptotic factor in endothelial cells relevant to high-altitude pulmonary edema. |
In vivo HAPE rat model validation; siRNA knockdown in HUVECs; apoptosis assays; permeability assays |
Apoptosis |
Low |
39110356
|
| 2024 |
RPLP0 promotes HCC cell proliferation, invasion, and migration partly through activation of the JAK/STAT3 pathway; miR-450b-5p directly targets the RPLP0 3'UTR (validated by luciferase reporter assay) to downregulate RPLP0 and suppress this pathway. |
Luciferase reporter assay; siRNA knockdown; xenograft tumor assay; western blotting for JAK/STAT3 pathway components |
Translational oncology |
Low |
39383650
|
| 2025 |
c-Myc directly binds the RPLP0 promoter and activates its transcription; RPLP0 in turn activates the JAK2/STAT3 pathway via ROS suppression, which upregulates c-Myc, forming a positive feedback loop driving HCC progression. |
Chromatin immunoprecipitation (ChIP); dual luciferase promoter assay; siRNA knockdown; ROS measurement; western blotting for JAK2/STAT3/c-Myc |
International journal of oncology |
Medium |
41312719
|